Thermostable FGF2 developed and manufactured by Enantis (patents granted – US 11,746,135, EP3380508B1, CA3006388C, JP7131772B2, KR102650035B1, SG11201804402W, AU2016359722)

 

COMPETITIVE ADVANTAGE

 

Much lower dosage needed 

Measured by NIH/3T3 fibroblast cell proliferation

* 5-times lower dosage required, but up to 20-times lower dosage required if used in B8 media formulation (Kuo et al., 2020)

 

Longer half-life (50-times)

Measured by activation of ERK in human ESC CCTL14 culture

 

Fully retained biological activity

Tested in BAF3 cells expressing FGFR2c receptor

 

No need for stabilizing additives

Temperature stability enhanced by 19°C – measured by circular dichroism spectroscopy

 

Animal-free product

 

Available sizes: 50 ug, 100 ug, 500 ug and 1 mg

Lead time: up to 2 weeks

Contact us for better priced bulk orders